Skip to main content
RENALYTIX PLC logo

RENALYTIX PLC — Investor Relations & Filings

Ticker · RENX ISIN · GB00BYWL4Y04 LEI · 213800NTOH3FK3WER551 IL Human health and social work activities
Open in API
Filings indexed 444 across all filing types
Latest filing 2026-05-18 Major Shareholding Noti…
Country GB United Kingdom
Listing IL RENX

About RENALYTIX PLC

https://renalytix.com/

Renalytix is a diagnostics company that develops artificial intelligence-enabled solutions for the clinical management of kidney disease. Its flagship product, KidneyIntelX.dkd™, is an FDA-authorized blood test for adults with type 2 diabetes and early-stage chronic kidney disease. The test utilizes a proprietary bioprognostic™ methodology to analyze biomarkers and clinical data, predicting the risk of a progressive decline in kidney function over a five-year period. This risk assessment enables clinicians to identify high-risk patients and implement targeted, guideline-recommended treatments to slow disease progression and improve outcomes.

Recent filings

Filing Released Lang Actions
Holding(s) in Company
Major Shareholding Notification Classification · 92% confidence The document is an RNS regulatory filing titled “TR-1: Standard form for notification of major holdings,” containing details of UBS Group AG’s voting rights crossing below the 5% threshold in Renalytix PLC. This matches the definition for a Major Shareholding Notification under DTR 5.1. It is not an earnings release, management report, or other category, but specifically a threshold notification of significant share ownership. Therefore, it should be classified as Major Shareholding Notification (MRQ).
2026-05-18 English
Holding(s) in Company
Regulatory Filings
2026-05-05 English
Holding(s) in Company
Regulatory Filings
2026-05-05 English
Holding(s) in Company
Major Shareholding Notification Classification · 100% confidence The document is a TR-1 form notification of major holdings, which is a regulatory filing used to notify changes in significant share ownership levels. It includes details about the issuer, the shareholder, the percentage of voting rights held, and the date the threshold was crossed. The document specifically states that UBS trading book holdings fell below 5%, triggering the notification. This type of document corresponds to a Major Shareholding Notification. The document length is 8054 characters, which is sufficient to contain substantive information, not just an announcement. Therefore, the correct classification is Major Shareholding Notification (MRQ).
2026-05-01 English
Holding(s) in Company
Major Shareholding Notification Classification · 95% confidence The document is a TR-1 standard form for notification of major holdings under DTR5, detailing a shareholder crossing a voting rights threshold for Renalytix PLC. This is a Major Shareholding Notification.
2026-04-29 English
Holding(s) in Company
Major Shareholding Notification Classification · 90% confidence The document is an RNS “TR-1: Standard form for notification of major holdings” showing a threshold crossing in voting rights under DTR5, detailing the percentage of voting rights and parties involved. This exactly matches a Major Shareholding Notification (Code: MRQ).
2026-04-23 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.